Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: A review

Cancer Control

Volumn 10, Issue 1, 2003, Pages 57-65

  Van Laar, Jacob M ^a   Tyndall, Alan ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; MORTALITY; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROGNOSIS; RELAPSE; REMISSION; REVIEW; RHEUMATIC DISEASE; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0037286874     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480301000107     Document Type: Review

References (62)

1. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340-350.
2. Snowden JA, Atkinson K, Kearney P, et al. Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient. Bone Marrow Transplant. 1997;20:71-73.
3. Sturfelt G, Lenhoff S, Sallerfors B, et al. Transplantation with allogeneic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis. 1996;55:638-641.
4. Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect. 1999;107:693-700.
5. Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum. 2001;44:2746-2749.
6. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437-2444.
7. Furst DE. Stem cell transplantation for autoimmune disease: progress and problems. Curr Opin Rheumatol. 2002;14:220-224.
8. Morton JI, Siegel BV. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci U S A. 1974;71:2162-2165.
9. Morton JI, Siegel BV, Moore RD. Transplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells. Transplantation. 1975;19:464-469.
10. Jyonouchi H, Kincade PW, Good RA, et al. Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol. 1981;127:1232-1235.
11. Ikehara S, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A. 1985;82:2483-2487.
12. van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol. 2000;20:10-16.
13. Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, et al. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant. 1991;8:333-338.
14. van Gelder M, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant. 1995;16:343-351.
15. van Gelder M, Mulder AH, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation. 1996;62:810-818.
16. van Gelder M, van Bekkum DW. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant. 1996;18:1029-1034.
17. van Bekkum DW. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant. 2000;25:357-364.
18. Baldwin JL, Storb R, Thomas ED, et al. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum. 1977;20:1043-1048.
19. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant. 1986;1:237-239.
20. Lowenthal RM, Cohen ML, Atkinson K, et al. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol. 1993;20:137-140.
21. McKendry RJ, Huebsch L, Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13-year followup. Arthritis Rheum. 1996;39:1246-1253.
22. Snowden JA, Patton WN, O'Donnell JL, et al. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997;19:1247-1250.
23. Meloni G, Capria S, Vignetti M, et al. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood. 1997;89:4659.
24. Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood. 1996;88:3621-3625.
25. Atkinson K, Nivison-Smith I, Hawkins T. Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry. Aust N Z J Med. 1997;27:408-419.
26. Alegre A, Diaz-Mediavilla J, San-Miguel J, et al. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Espanol de Transplante HematopoyeticoGETH) and PETHEMA. Bone Marrow Transplant. 1998;21:133-140.
27. Antman KH, Rowlings PA, Vaughan WP, et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol. 1997;15:1870-1879.
28. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol. 1997;36:390-392.
29. Oppenshaw H, Nash RA, McSweeney PA. High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review. Biol Blood Marrow Transplant. 2002;8:233-248.
30. Joske DJ, Ma DT, Langlands DR, et al. Autologous bone-marrow transplantation for rheumatoid arthritis. Lancet. 1997;350:337-338.
31. Durez P, Toungouz M, Schandene L, et al. Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet. 1998;352:881.
32. Burt RK, Georganas C, Schroeder J, et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum. 1999;42:2281-2285.
33. Snowden JA, Biggs JC, Milliken ST, et al. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum. 1999;42:2286-2292.
34. Bingham SJ, Snowden J, McGonagle D, et al. Autologous stem cell transplantation for rheumatoid arthritis-interim report of 6 patients. J Rheumatol Suppl. 2001;64:21-24.
35. Pavletic SZ, O'Dell JR, Pirruccello SJ, et al. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience. J Rheumatol Suppl. 2001;28:13-20.
36. Verburg RJ, Kruize AA, van den Hoogen FH, et al. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum. 2001;44:754-760.
37. Verburg RJ, Sont JK, Kruize AA, et al. High-dose cyclophosphamide followed by autologous stem cell transplantation for the treatment of intractable rheumatoid arthritis: a 2-year clinical and immunological follow-up. Arthritis Rheum. 2001;44:S274.
38. Verburg RJ, Toes RE, Fibbe WE, et al. High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol. 2002;63:627-637.
39. Bingham S,Veale D, Fearon U, et al. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: shortterm efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum. 2002;46:837-839.
40. Moore J, Milliken S, Ma D, et al. Peripheral blood stem cell transplantation for rheumatoid arthritis: Australian experience. J Rheumatol. 2001;28:8-12.
41. McColl G, Kohsaka H, Szer J, et al. High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med. 1999;131:507-509.
42. Snowden J, Moore J, Passweg JR, et al. Autologous stem cell transplantation in rheumatoid arthritis. Blood. 2001;98:860a.
43. Quartier P, Prieur AM, Fischer A. Haemopoietic stem-cell transplantation for juvenile chronic arthritis. Lancet. 1999;353:1885-1886.
44. Wulffraat N, van Royen A, Bierings M, et al. Autologous haemopoietic stem cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet. 1999;353:550-553.
45. Furst DE, Clements PJ, Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol Suppl. 1997;48:53-57.
46. Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum. 2001;44:2828-2835.
47. Tyndall A, Black C, Finke J, et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet. 1997;349:254.
48. White B, Moore WC, Wigley FM, et al. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med. 2000;132:947-954.
49. Binks M, Passweg JR, Furst D, et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis. 2001; 60:577-584.
50. McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood. 2002;100:1602-1610.
51. Traynor AE, Barr WG, Rosa RM, et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Arthritis Rheum. 2002;46:2917-2923.
52. Fouillard L, Gorin NC, Laporte JP, et al. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus. 1999;8:320-323.
53. Musso M, Porretto F, Crescimanno A, et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus. 1998;7:492-494.
54. Wulffraat NM, Sanders EA, Kamphuis SS, et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum. 2001;44:728-731.
55. Brodsky RA, Petri M, Smith BD, et al. Immunoablative highdose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med. 1998;129:1031-1035.
56. Burt RK, Fassas A, Snowden J, et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant. 2001;28:1-12.
57. Tyndall A, Fassas A, Passweg J, et al. Autologous haemopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality. Bone Marrow Transplant. 1999;24:729-734.
58. Verburg RJ, Mahabali SD, Stiggelbout AM, et al. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists. J Rheumatol. 2002;29:1653-1658.
59. Verburg RJ, Sont JK, Vliet Vlieland TP, et al. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis. J Rheumatol. 2001;28:719-727.
60. Uhrin Z, Wang BW, Matsuda Y, et al. Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival. Arthritis Rheum. 2001;44:1525-1528.
61. ASTIStrial: Autologous Stemcell Transplantation International Scleroderma Trial. Available at: http://www.astistrial.com. Accessed October 16, 2002.
62. Kashyap A, Passweg J, Tyndall A. Autologous hematopoietic stem cell transplant conditioning regimens for the treatment of severe autoimmune diseases. In: Dicke KA, Keating A, eds. Autologous Blood and Marrow Transplantation: Proceedings of the 10th International Symposium, Dallas, Texas, 2000. Charlottesville, Va: Carden Jennings Pub Co; 2001.